This marks the first inclusion of a new kind of depression medication in the subsidised list in thirty years, anticipated to benefit as many as 30,000 Australians.

Alexis Hutcheon and Samuel Hockey live with depression that’s resistant to treatment.

Associate Professor Liz Scott, a consultant psychiatrist, mentioned, “We anticipate that for some individuals, it will bring about remission, and possibly sustained long-term remission.”

Patients start with treatment twice a week then extend to weekly and fortnightly doses.

They have to fast for two hours before and be supervised after receiving the spray.

They also can’t drive for the rest of that day.

After years of testing it’s being added to the PBS.

Hutcheon called it a “gamechanger” and Hockley said it was “just a miracle”.

The spray will officially be listed on the PBS on Thursday, reducing the price from about $800 a week to $7.70 per dose for concession card holders, and $31.60 for everyone else.

Patients will also have to cover the cost of visiting a private clinic to be given the medication and be monitored.